Langston Tillman

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Low Density Lipoprotein

Randomized Controlled Trial

Helicobacter Pylori

Top Venues

Science advances

This page only lists publications with an associated author ORCID identifier.

Publications

Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)
Xiaomin Jiang, Taokun Luo, Kaiting Yang, Morten J Lee, Jing Liu, Langston Tillman, Wenyao Zhen, Ralph R Weichselbaum, Wenbin Lin
STING activation disrupts tumor vasculature to overcome the EPR limitation and increase drug deposition. Science advances 10 (29) (2024)